Studying CBD
No Result
View All Result
  • Home
  • CBD
  • About CBD
  • What is CBD
  • Home
  • CBD
  • About CBD
  • What is CBD
No Result
View All Result
Studying CBD
No Result
View All Result
Home About CBD

She’s considered a rock star exec. in the cannabis and CBD world – and she’s headlining this Oct. 2 event.

Peter F. by Peter F.
September 28, 2019
in About CBD
38 1
0
She’s considered a rock star exec. in the cannabis and CBD world – and she’s headlining this Oct. 2 event.
32
SHARES
359
VIEWS
Share on TwitterShare on Facebook

[ad_1]

As the medical marijuana program prepares to expand in the Garden State, some of the leading women in the cannabis industry will share their stories at the NJ Cannabis Insider event on Oct. 2.

Beth Stavola, the chief strategy officer of iAnthus, the former COO of MPX and co-founder of CBD For Life, will be among the many power players participating in our all-day, multi-track panel event at the New Jersey Convention and Exposition Center in Edison. Click here to buy your tickets now.

The NJ Cannabis Insider Fall Live event is focused on the expansion of the medical marijuana, the hemp and CBD industries, as well as where the state stands now on adult-use cannabis. Find the full lineup here: Get a head start in N.J.’s growing cannabis industry.

Stavola will deliver a keynote speech about her rise in the burgeoning cannabis industry and the movement is heading.

iAnthus, which won one of the coveted six medical licenses in the program’s initial expansion as MPX, should have plants in the ground by early December and could open its Atlantic City area dispensary by the end of the first quarter of 2020, she told NJ Cannabis Insider.

But she says there’s still plenty of room for more players following the latest Request for Applications round.

“I personally agree that there is plenty of room for those licenses,” Stavola told NJ Cannabis Insider last week. “We believe that at iAnthus, New Jersey will be a very healthy market for these companies and consumers.”

RELATED  Why consumers are claiming positive drug test results after using CBD oil - WJLA

Among other topics like the status of the CBD and hemp industries and navigating the business for newcomers, the day will feature a panel of women leaders in the business. Charlana McKeithen, executive director of Garden State NORML, Sarah Fajardo, marijuana policy director of ACLU-NJ, and Colleen Mahr, president of the N.J. League of Municipalities, will share their journeys and advice.

“There’s still a lot of challenges in the space,” McKeithen told NJ Cannabis Insider. “Building relationships with the right organizations helps.”

Many advocates and industry leaders have called for diversity as the state’s cannabis industry grows. A new round of medical licenses set aside 15 percent are for women, veterans and those with disabilities and another 15 percent for minorities.

“It’s a good start, but we have a lot more work to do,” McKeithen said. “We need resources to be able to have economic development, like loans for these smaller organizations, so that they can build and have a chance to succeed like the other alternative treatment centers that are up and running.”

The event packs in a full day of programming, panel discussions, networking opportunities and lunch. Space is limited and tickets won’t last. Regular price tickets are $180. NJ Cannabis Insider members get discounted entry.

NJ Cannabis Insider is produced by NJ Advance Media, which also provides content for NJ.com, The Star-Ledger and other affiliated papers. Subscribe here for exclusive insider information from NJ Cannabis Insider.

[ad_2]

Source link

Tweet8Share13Share3Share
Peter F.

Peter F.

We study the effects of cannabidiol (CBD), a non-psychoactive component of cannabis that does not produce the high associated with smoking or using it."There is a lot of debate on the health effects of marijuana and the use of cannabinoids, which are a group of compounds found in marijuana that have anti-inflammatory, pain-relieving, anti-nausea and anti-emetic properties. However, there is a lack of solid scientific evidence to guide us in the application of cannabis therapeutics."

No Result
View All Result
  • Privacy Policy
  • Contact
  • About us

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.. For more information contact Info@sdmediagrp.comContinuePrivacy policy